NCT02086175 A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT02057432 Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO) Status COMPLETED Phase NA
NCT02041429 Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca Status COMPLETED Phase PHASE1/PHASE2
NCT02041325 Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias Status COMPLETED Phase PHASE2
NCT02040857 Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer Status COMPLETED Phase PHASE2
NCT02036476 Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Status TERMINATED Phase PHASE2
NCT02025010 Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01983410 A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01965353 A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1